Arul Chinnaiyan

Founder at Armune BioScience, Inc.

Arul Chinnaiyan

Arul Chinnaiyan

Founder at Armune BioScience, Inc.

Overview
Career Highlights

Compendia Bioscience, Inc.
Armune BioScience, Inc.
Oncofusion Therapeutics, Inc.

RelSci Relationships

2352

Number of Boards

8

Number of Awards

1

Relationships
RelSci Relationships are individuals Arul Chinnaiyan likely has professional access to. A relationship does not necessarily indicate a personal connection.

Director at University of Michigan - Center for Computational Medicine and Bioinformatics

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Armune BioScience, Inc.

Relationship likelihood: Strong

Professor at Johns Hopkins University

Relationship likelihood: Strong

Vice Chairman, Scientific Advisory Board at Armune BioScience, Inc.

Relationship likelihood: Strong

Co-Founder at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

President & Director at Barnstead Thermolyne Corp.

Relationship likelihood: Strong

Chair, Department of Radiation Oncology at University of Michigan Medical School

Relationship likelihood: Strong

Chairman, Department of Internal Medicine at University of Michigan Medical School

Relationship likelihood: Strong

Michael & Stella Chernow Professor of Urologic Sciences at Columbia University Medical Center

Relationship likelihood: Strong

European Principal Investigator at BioXcel Therapeutics, Inc.

Relationship likelihood: Strong

Paths to Arul Chinnaiyan
Potential Connections via
Relationship Science
You
Arul Chinnaiyan
Founder at Armune BioScience, Inc.
Education
Ph.D. in Pathology

University of Michigan founded its medical school in 1850, it immediately assumed a leadership role in American academic medicine. Medical School was the University's first professional school, and since graduating its first class of six students in 1851 a group which paid a mere $5 for two years of medical education. They have become a leader in preparing the physicians and scientists of the future.

B.S. in Cellular & Molecular Biology

The University of Michigan (UM, U-M, UMich, or U of M), frequently referred to as simply Michigan, is a public research university located in Ann Arbor, Michigan, United States. It is the state's oldest university and the flagship campus of the University of Michigan. It is one of the original eight Public Ivy universities and is one of the founding members of the Association of American Universities. It has been ranked among the top five research universities in the US, and among the top 20 universities in the world. U-M also has satellite campuses in Flint and Dearborn.

Memberships
Fellow
2015 - Current

The National Academy of Inventors® is a member organization comprising U.S. and international universities, and governmental and non-profit research institutes, with over 4,000 individual inventor members and Fellows spanning more than 250 institutions worldwide. The NAI publishes the multidisciplinary journal Technology and Innovation, Journal of the National Academy of Inventors®. Membership with the NAI is available through local university and non-profit research institute chapters only. To join your university or non-profit research institute’s chapter, you must be a member of your institution’s academic community (includes faculty, staff, alumni and affiliates) and have a patent issued from the USPTO. Universities and non-profit research institutes are invited to Establish a Local Chapter of the NAI, to recognize and encourage their community of inventors.

Career History
Co-Founder
2006 - Current

Compendia Bioscience, Inc. provides information solutions for oncology drug discovery. The company was founded by Daniel D. Rhodes and Arul Chinnaiyan in February 2006 and is headquartered in Canton, MI.

Founder
Current

Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI.

Director, Division of Pathology Research Informatics
Current

University of Michigan founded its medical school in 1850, it immediately assumed a leadership role in American academic medicine. Medical School was the University's first professional school, and since graduating its first class of six students in 1851 a group which paid a mere $5 for two years of medical education. They have become a leader in preparing the physicians and scientists of the future.

Boards & Committees
Chairman, Scientific Advisory Board
Current

Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI.

Member, Scientific Advisory Board
Current

MolecularMD Corp. develops and commercializes molecular diagnostics for oncology applications. Its tests are designed to assist pharmaceutical companies with selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. The firm integrates gold-standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development, including FDA approval and commercialization of in vitro companion diagnostic tests for novel anticancer agents. The company was founded by Brian Druker, Sheridan G. Snyder, and Chad D. Galderisi in 2005 and is headquartered in Portland, OR.

Member, Scientific Advisory Board
Prior - 2016

Metabolon, Inc. operates as a health technology company. It offers precision medicine, clinical diagnostic, and metabolomics services. The firm serves to the pharmaceutical, biotechnology, consumer product industries. The company was founded in 2000 and is headquartered in Morrisville, NC.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$5,000 - $10K
2016

The University of Michigan (UM, U-M, UMich, or U of M), frequently referred to as simply Michigan, is a public research university located in Ann Arbor, Michigan, United States. It is the state's oldest university and the flagship campus of the University of Michigan. It is one of the original eight Public Ivy universities and is one of the founding members of the Association of American Universities. It has been ranked among the top five research universities in the US, and among the top 20 universities in the world. U-M also has satellite campuses in Flint and Dearborn.

$1,000 - $2,499
2006

TO EMPOWER UNDERSERVED CHILDREN AND THEIR FAMILIES IN NICARAGUA THROUGH EDUCATION AND NUTRITION.

Investments
Details Hidden

Oncofusion Therapeutics, Inc. operates as oncology development company. It specializes in BET Bromodomain Inhibitors, ERG Inhibitors, EZH2-EED Inhibitors and MMSET/NSD2 Inhibitors. The company was founded in 2012 by Arul M. Chinnaiyan and Shaomeng Wang and is headquartered in Ann Arbor, MI.

Details Hidden

Compendia Bioscience, Inc. provides information solutions for oncology drug discovery. The company was founded by Daniel D. Rhodes and Arul Chinnaiyan in February 2006 and is headquartered in Canton, MI.

Awards & Honors
American Association for Cancer Research - Outstanding Achievement Award , Cancer Research
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Arul Chinnaiyan. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Arul Chinnaiyan's profile does not indicate a business or promotional relationship of any kind between RelSci and Arul Chinnaiyan.